Max Healthcare Institute Ltd (MAXHEALTH) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Max Healthcare Institute Ltd on NSE and BSE, with an AI summary of each filing.
Schedule of Investor Conference
Intimation · 05 Nov 2026, 12:15 am
Max Healthcare Announces Participation in Upcoming Physical Investor Conferences Max Healthcare Institute Limited representatives will participate in two physical investor conferences in Nov'26. The company is scheduled to attend the Goldman 15th India CIO Tour on 13th Nov'26 in New Delhi for group meetings, followed by the 29th CITIC CLSA India Forum on 17th Nov'26 at Nariman Point, Mumbai, for one-on-one and group interactions. The management confirmed that no unpublished price-sensitive information will be shared during these scheduled sessions.
Audio Recording of Earnings Call held on November 3, 2026
Audio / Video · 04 Nov 2026, 3:53 am
Max Healthcare Releases Audio Recording of Q2/H1 FY27 Earnings Call Max Healthcare Institute Limited announced that the audio recording of its earnings conference call held on 3rd Nov'26 is available on the company's website. The call discussed the financial results for the quarter and half-year ended 30th Sep'26.
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 04 Nov 2026, 3:43 am
Max Healthcare NCLT Hearing on Kalinga Hospital Matter Adjourned to Dec'26 The NCLT Cuttack Bench heard petitions filed by BRS Capital Two Pte. Limited against Max Healthcare Institute Limited, its subsidiary Kalinga Hospital Ltd. (KHL), and KHL's former majority shareholder on 30th Oct'26. Upon request from all counsels, the tribunal deferred the proceedings and listed the matter for further consideration on 14th Dec'26. The company received the formal order copy on 3rd Nov'26.
Change in Senior Management Personnel
Change in Management · 30 Oct 2026, 8:27 pm
Max Healthcare Q2 FY27 Results and Expansion Approvals Max Healthcare Institute reported consolidated revenue from operations of ₹2,56,921 lakh for the quarter ended 30th Sep'26, up 20.31% YoY, with net profit after tax reaching ₹41,445 lakh (PAT attributable to owners at ₹41,494 lakh). The board approved capex via subsidiary Crosslay Remedies: ~₹93 crore to add ~85 beds at MSSH Noida within 15 months, and ~₹97 crore to add ~60 beds at MSSH Vaishali within 24 months. Additionally, the Sector-56 Gurugram hospital project cost was revised to ~₹1,143 crore, targeted for completion by Apr'27.
Presentation of earnings update for the quarter and half year ended September 30, 2026
Investor Presentation · 30 Oct 2026, 8:24 pm
Max Healthcare Q2 FY27 Results: Gross Revenue Rises 20% YoY to ₹3,219 Cr Max Healthcare reported Q2 FY27 network gross revenue of ₹3,219 Cr, up 20% YoY (+8% QoQ), with operating EBITDA rising 18% YoY to ₹820 Cr (26.8% margin) and PAT growing 10% YoY to ₹448 Cr. Operational bed capacity reached 5,518 (+16% YoY) with 77% occupancy and an 8% increase in ARPP to ₹2.31 lakh. International patient revenue surged 33% YoY to ₹307 Cr. The board approved ₹415 Cr in capex for 209 brownfield beds across existing facilities, while net debt stood at ₹2,369 Cr as of 30th Sep'26.
Press Release - Max Healthcare Q2 revenue rises to Rs. 3,219 Cr, registering growth of 20% YoY; Q2 PAT stood at Rs. 448 Cr, growth of 10% YoY
Press Release · 30 Oct 2026, 8:22 pm
Max Healthcare Posts Strong Q2 Performance With Gross Revenue Up 20% YoY Max Healthcare reported Q2 gross revenue of ₹3,219 Cr, up 20% YoY and 8% QoQ, driven by higher occupied bed days. Normalized network PAT grew 10% YoY to ₹448 Cr with a 14.7% margin, while operating EBITDA rose 18% YoY to ₹820 Cr. ARPP climbed 8% YoY to ₹2.31 lakh amid 77% bed occupancy across 5,518 operational beds (+16% YoY). Board approved ₹415 Cr capex for 209 brownfield beds. Free cash flow from operations reached ₹500 Cr, with net debt closing at ₹2,369 Cr as of 30th Sep'26.
Outcome of Board Meeting held on October 30, 2026
Outcome · 30 Oct 2026, 8:18 pm
Result - Financial Results for the quarter and half year ended September 30, 2026
Financial Result · 30 Oct 2026, 8:15 pm
Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 30 Oct 2026, 8:14 pm
Max Healthcare Institute Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 2,56,921 (+20.3% YoY | +8.6% QoQ) ■ EBITDA: 71,149 (+23.7% YoY | +18.9% QoQ) ■ EBITDA Margin (%): 27.7 (+76 bps YoY | +240 bps QoQ) ■ PAT: 41,494 (-15.5% YoY | +28.7% QoQ) ■ EPS (INR): 4.24 (-15.5% YoY | +28.5% QoQ)
Allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
Others (Uncategorized) · 30 Oct 2026, 4:32 pm
Max Healthcare Approves Equity Share Allotment Under ESOP Scheme 2022 On 30th Oct'26, Max Healthcare Institute's Nomination & Remuneration Committee approved the allotment of 16,803 fully paid-up equity shares (face value ₹10) pursuant to the exercise of vested options under ESOP Scheme 2022 at an exercise price of ₹350 per share (₹340 premium). Consequently, the company's total issued equity base expanded from 97,33,10,251 to 97,33,27,054 shares, increasing paid-up equity share capital from ₹973.31 Cr to ₹973.33 Cr. The newly allotted shares rank pari passu with existing equity shares.
Grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
Others (Uncategorized) · 30 Oct 2026, 4:27 pm
Max Healthcare Approves Grant of 95,000 ESOPs at ₹800 Per Option Max Healthcare Institute Limited's Nomination and Remuneration Committee approved the grant of 95,000 stock options to eligible employees on 30th Oct'26 under the MHIL ESOP-2022 scheme. Each option is convertible into one fully paid-up equity share of ₹10 face value at an exercise price of ₹800 per share. The options carry a vesting period ranging from 1 to 5 years from the grant date, subject to pre-vesting conditions, and must be exercised within 3 years from their respective vesting dates.
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 30 Oct 2026, 2:55 am
Max Healthcare Reports NCLT Adjournment on Kalinga Hospital Petitions Max Healthcare Institute disclosed that petitions filed by legal representatives of BRS Capital Two Pte. Limited against the company, its subsidiary Kalinga Hospital Ltd. (KHL), and KHL’s former majority shareholder were not heard on 29th Oct'26 due to time constraints. The National Company Law Tribunal (NCLT), Cuttack Bench, has adjourned the matter to 30th Oct'26 for further hearing. The proceedings follow the company's prior intimation dated 29th Sep'26 regarding the ongoing litigation surrounding its majority equity acquisition in KHL.
Max Healthcare Institute Limited has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 30 Oct 2026, 5:30 am
Schedule of Earnings Call for Investors and Analysts
Intimation · 03 Nov 2026, 12:00 pm
Max Healthcare Schedules Q2 & H1 FY27 Earnings Call for 3rd Nov'26 Max Healthcare Institute Limited will host an earnings conference call for investors and analysts on 3rd Nov'26 at 12:00 PM IST to discuss its financial performance for the quarter and half-year ended 30th Sep'26. The company will declare its Q2 and H1 FY27 financial results on 30th Oct'26, preceding the call. Senior management will lead the discussion, which will be followed by an interactive Q&A session. Max Healthcare currently operates 21 healthcare facilities comprising over 6,100 beds across India.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 30 Oct 2026, 5:30 am
Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve unaudited standalone ....
Intimation · 30 Oct 2026, 5:30 am
Max Healthcare Board Meeting Scheduled for 30th Oct'26 to Consider Q2 Results Max Healthcare Institute Limited has scheduled a Board of Directors meeting on 30th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed for all designated persons and their immediate relatives until 48 hours following the declaration of the financial results.
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 20 Oct 2026, 3:27 am
Max Healthcare Approves PRSU Scheme 2026 and Strategic MOA Alterations Max Healthcare Institute shareholders approved the Performance Linked Restricted Stock Unit (PRSU) Scheme 2026 via postal ballot on 19th Oct'26. The scheme covers up to 73.50 lakh equity shares (~0.76% of paid-up capital as of 13th Aug'26) for eligible employees of the company and subsidiaries at an exercise price equal to face value (₹10/share). Additionally, members approved altering the Memorandum of Association's Main Objects Clause to expand into medical education/colleges, pharmaceuticals and radiopharmaceuticals manufacturing via particle accelerator facilities, and in-house food and beverage services.
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 16 Oct 2026, 9:16 pm
Max Healthcare Assigned ESG Rating of 66 by NSE Sustainability for FY26 Max Healthcare Institute Limited received an intimation on 15th Oct'26 from SEBI-registered provider NSE Sustainability Ratings and Analytics Limited assigning the company an ESG rating of '66' for FY25-26. The rating was evaluated independently based on public disclosures, without direct engagement from the company.
Rating by CARE Ratings Limited
Others (Uncategorized) · 09 Oct 2026, 5:28 pm
CARE Reaffirms Max Healthcare’s Credit Ratings with Enhanced Long-Term Facilities CARE Ratings has reaffirmed its credit ratings for Max Healthcare Institute Limited, as communicated on 8th Oct'26. The rating for long-term bank facilities was reaffirmed at 'CARE AA+; Stable', with the facility amount enhanced from ₹1,296.02 Cr to ₹1,818.88 Cr. Additionally, short-term bank facilities of ₹80.00 Cr were reaffirmed at 'CARE A1+'.
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 30 Sept 2026, 4:11 am
NCLT Adjourns BRS Capital Litigation Regarding Max Healthcare's Kalinga Hospital Stake The NCLT Cuttack Bench could not hear petitions filed by BRS Capital Two Pte. Limited against Max Healthcare Institute, its subsidiary Kalinga Hospital Ltd. (KHL), and the selling shareholder on 28th Sep'26 due to paucity of time. Consequently, the tribunal adjourned the matter for further hearing to 29th Oct'26. Max Healthcare confirmed receipt of the formal adjournment order on 29th Sep'26.
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 18 Sept 2026, 10:00 pm
Max Healthcare Awarded ‘Leader’ ESG Rating by Niche99 Max Healthcare Institute received intimation on 17th Sep'26 from SEBI-registered ESG rating provider Niche Ninety Nine Capability and Certifications (OPC) Private Limited (Niche99), assigning the company an ESG rating of '72'. This score places the company in the 'Leader' category. The rating was independently assigned by Niche99 based on publicly available disclosures without formal engagement by Max Healthcare.
Schedule of Investor Conference
Intimation · 14 Sept 2026, 8:39 pm
Max Healthcare to Attend J.P. Morgan India Conference on 21st Sep'26 Max Healthcare Institute Limited announced that its representatives will participate in the J.P. Morgan India Conference 2026 on 21st Sep'26 at The St. Regis, Mumbai. The physical event will comprise both one-on-one and group meetings. The company confirmed that no unpublished price-sensitive information will be shared during the interactions.
Schedule of Investor Conference
Intimation · 14 Sept 2026, 8:29 pm
Max Healthcare to Participate in Jefferies 5th India Forum 2026 Max Healthcare Institute Limited announced that company representatives will participate in Jefferies' 5th India Forum 2026 on 16th Sep'26 in Gurgaon. The physical event will feature one-on-one and group meetings at The Oberoi. The company confirmed that no unpublished price-sensitive information will be shared during the conference, and no additional one-on-one meetings are scheduled before or after the event.
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 11 Sept 2026, 9:33 pm
Max Healthcare Discloses NCLT Proceedings Update Regarding Kalinga Hospital Acquisition Max Healthcare Institute announced an update regarding petitions filed by BRS Capital Two Pte. Ltd. before NCLT Cuttack against the company and subsidiary Kalinga Hospital Ltd. (KHL). Following a hearing on 8th Sep'26 on interlocutory petitions seeking interim reliefs, the NCLT directed respondents, including Max Healthcare, to file their replies within one week. The company received the formal order on 10th Sep'26, and the tribunal has scheduled the next hearing for 28th Sep'26.
Update on infusion of funds in Kalinga Hospital Ltd.
Others (Uncategorized) · 08 Sept 2026, 3:22 am
Max Healthcare Raises Stake in Kalinga Hospital to 66.15% via Rights Issue Max Healthcare Institute Limited has subscribed to a rights issue of its subsidiary, Kalinga Hospital Ltd. (KHL), infusing ~₹87.87 crore. On 7th Sep'26, the company received confirmation of the allotment of 50,21,212 equity shares in KHL. Following this allotment, Max Healthcare's equity shareholding in KHL has increased from ~58.28% to ~66.15%, with KHL continuing to operate as a subsidiary.